MKI67 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.05842026651726E-12 |
Normal-vs-Stage2 |
9.18380000047847E-07 |
Normal-vs-Stage3 |
2.17399986901512E-10 |
Normal-vs-Stage4 |
7.27479999573788E-08 |
Stage1-vs-Stage2 |
7.291000E-01 |
Stage1-vs-Stage3 |
1.075570E-02 |
Stage1-vs-Stage4 |
6.805700E-04 |
Stage2-vs-Stage3 |
7.059800E-02 |
Stage2-vs-Stage4 |
2.000200E-03 |
Stage3-vs-Stage4 |
4.048300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
2.648600E-04 |
Normal-vs-Asian |
1.287580E-01 |
Caucasian-vs-AfricanAmerican |
9.820500E-04 |
Caucasian-vs-Asian |
4.766400E-01 |
AfricanAmerican-vs-Asian |
2.680000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.6269208202857E-12 |
Normal-vs-Female |
3.53539419961635E-12 |
Male-vs-Female |
1.097160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.236900E-04 |
Normal-vs-Age(41-60Yrs) |
1.81532566756459E-12 |
Normal-vs-Age(61-80Yrs) |
1.94955163124177E-13 |
Normal-vs-Age(81-100Yrs) |
1.761820E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.499800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.765400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.070500E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.463200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.604000E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.702480E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.004330E-02 |
Normal-vs-Grade 2 |
1.08859588010546E-11 |
Normal-vs-Grade 3 |
7.0832228971085E-14 |
Normal-vs-Grade 4 |
1.59069999949857E-07 |
Grade 1-vs-Grade 2 |
1.534640E-01 |
Grade 1-vs-Grade 3 |
8.342700E-03 |
Grade 1-vs-Grade 4 |
1.359930E-04 |
Grade 2-vs-Grade 3 |
2.411800E-02 |
Grade 2-vs-Grade 4 |
4.846800E-04 |
Grade 3-vs-Grade 4 |
3.819900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.0971891717968E-12 |
Normal-vs-ccB subtype |
1.6242562850266E-13 |
ccA subtype-vs-ccB subtype |
7.64250000000466E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.73039360618077E-12 |
Normal-vs-N1 |
1.761340E-03 |
N0-vs-N1 |
3.231800E-02 |
|
|